Arix Bioscience plc 13D and 13G filings for Aura Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-10 4:37 pm Sale | 2022-12-31 | 13G | Aura Biosciences, Inc. AURA | Arix Bioscience plc | 1,508,483 4.100% | -91,593 (-5.72%) | Filing |
| 2022-02-10 4:35 pm Purchase | 2021-12-31 | 13G | Aura Biosciences, Inc. AURA | Arix Bioscience plc | 1,600,076 29.210% | 91,593 (+6.07%) | Filing |
| 2021-11-10 2:33 pm Purchase | 2021-11-02 | 13G | Aura Biosciences, Inc. AURA | Arix Bioscience plc | 1,508,483 5.310% | 1,508,483 (New Position) | Filing |